{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:43:40Z","timestamp":1780069420879,"version":"3.54.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/20695-3"],"award-info":[{"award-number":["2013\/20695-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2009\/52825-8"],"award-info":[{"award-number":["2009\/52825-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","award":["554535\/2005-0"],"award-info":[{"award-number":["554535\/2005-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Associa\u00e7\u00e3o Beneficente Alzira Denise Hertzog da Silva"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00406-018-0905-3","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T04:52:54Z","timestamp":1527569574000},"page":"963-972","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer\u2019s disease patients"],"prefix":"10.1007","volume":"269","author":[{"given":"Jessyka Maria de Fran\u00e7a","family":"Bram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda Leme","family":"Talib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Passarelli Giroud","family":"Joaquim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamires Alves","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner Farid","family":"Gattaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orestes Vicente","family":"Forlenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"key":"905_CR1","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel H, Gertz H-J, Dresel S et al (2011) Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol 10:424\u2013435. https:\/\/doi.org\/10.1016\/S1474-4422(11)70077-1","journal-title":"Lancet Neurol"},{"key":"905_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 7:263\u2013269. https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimer\u2019s Dement"},{"key":"905_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jalz.2013.01.013","volume":"10","author":"K Henriksen","year":"2014","unstructured":"Henriksen K, O\u2019Bryant SE, Hampel H et al (2014) The future of blood-based biomarkers for Alzheimer\u2019s disease. Alzheimer\u2019s Dement 10:115\u2013131. https:\/\/doi.org\/10.1016\/j.jalz.2013.01.013","journal-title":"Alzheimer\u2019s Dement"},{"key":"905_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.dadm.2016.06.003","volume":"3","author":"SE O\u2019Bryant","year":"2016","unstructured":"O\u2019Bryant SE (2016) Introduction to special issue on Advances in blood-based biomarkers of Alzheimer\u2019s disease. Alzheimer\u2019s Dement (Amst Neth) 3:110\u2013112. https:\/\/doi.org\/10.1016\/j.dadm.2016.06.003","journal-title":"Alzheimer\u2019s Dement (Amst Neth)"},{"key":"905_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jalz.2016.09.014","volume":"13","author":"SE O\u2019Bryant","year":"2017","unstructured":"O\u2019Bryant SE, Mielke MM, Rissman RA et al (2017) Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimer\u2019s Dement 13:45\u201358. https:\/\/doi.org\/10.1016\/j.jalz.2016.09.014","journal-title":"Alzheimer\u2019s Dement"},{"key":"905_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cne.10760","volume":"463","author":"T Bussi\u00e8re","year":"2003","unstructured":"Bussi\u00e8re T, Giannakopoulos P, Bouras C et al (2003) Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer\u2019s disease: stereologic analysis of prefrontal cortex area 9. J Comp Neurol 463:281\u2013302. https:\/\/doi.org\/10.1002\/cne.10760","journal-title":"J Comp Neurol"},{"key":"905_CR7","volume-title":"Alzheimer\u2019s disease: unraveling the mystery. Alzheimer\u2019s Disease Education and Referral","author":"A Rodgers","year":"2008","unstructured":"Rodgers A (2008) Alzheimer\u2019s disease: unraveling the mystery. Alzheimer\u2019s Disease Education and Referral (ADEAR) Center, Silver Spring"},{"key":"905_CR8","doi-asserted-by":"publisher","first-page":"e4183","DOI":"10.1371\/journal.pone.0004183","volume":"4","author":"W Qin","year":"2009","unstructured":"Qin W, Ho L, Wang J et al (2009) S100A7, a novel Alzheimer\u2019s disease biomarker with non-amyloidogenic \u03b1-secretase activity acts via selective promotion of ADAM-10. PLoS One 4:e4183. https:\/\/doi.org\/10.1371\/journal.pone.0004183","journal-title":"PLoS One"},{"key":"905_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.4062\/biomolther.2012.20.3.245","volume":"20","author":"S-S Yoon","year":"2012","unstructured":"Yoon S-S, Jo SA (2012) Mechanisms of amyloid-\u03b2 peptide clearance: potential therapeutic targets for Alzheimer\u2019s disease. Biomol Ther (Seoul) 20:245\u2013255. https:\/\/doi.org\/10.4062\/biomolther.2012.20.3.245","journal-title":"Biomol Ther (Seoul)"},{"key":"905_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack","year":"2010","unstructured":"Jack CR, Knopman DS, Jagust WJ et al (2010) Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade. Lancet Neurol 9:119\u2013128. https:\/\/doi.org\/10.1016\/S1474-4422(09)70299-6","journal-title":"Lancet Neurol"},{"key":"905_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jalz.2014.02.004","volume":"11","author":"K Blennow","year":"2015","unstructured":"Blennow K, Dubois B, Fagan AM et al (2015) Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer\u2019s disease. Alzheimer\u2019s Dement 11:58\u201369. https:\/\/doi.org\/10.1016\/j.jalz.2014.02.004","journal-title":"Alzheimer\u2019s Dement"},{"key":"905_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","volume":"6","author":"K Blennow","year":"2017","unstructured":"Blennow K (2017) A review of fluid biomarkers for Alzheimer\u2019s disease: moving from CSF to blood. Neurol Ther 6:15\u201324. https:\/\/doi.org\/10.1007\/s40120-017-0073-9","journal-title":"Neurol Ther"},{"key":"905_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/alzrt164","volume":"5","author":"D Galasko","year":"2013","unstructured":"Galasko D, Golde TE (2013) Biomarkers for Alzheimer\u2019s disease in plasma, serum and blood\u2014conceptual and practical problems. Alzheimers Res Ther 5:10. https:\/\/doi.org\/10.1186\/alzrt164","journal-title":"Alzheimers Res Ther"},{"key":"905_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","volume":"3","author":"M Gissl\u00e9n","year":"2016","unstructured":"Gissl\u00e9n M, Price RW, Andreasson U et al (2016) Plasma Concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine 3:135\u2013140. https:\/\/doi.org\/10.1016\/j.ebiom.2015.11.036","journal-title":"EBioMedicine"},{"key":"905_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/sj.mp.4000552","volume":"4","author":"T Bayer","year":"1999","unstructured":"Bayer T, Cappai R, Masters C et al (1999) It all sticks together\u2014the APP-related family of proteins and Alzheimer\u2019s disease. Mol Psychiatry 4:524\u2013528. https:\/\/doi.org\/10.1038\/sj.mp.4000552","journal-title":"Mol Psychiatry"},{"key":"905_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0014-2999(00)00559-8","volume":"405","author":"M Luca Di","year":"2000","unstructured":"Di Luca M, Colciaghi F, Pastorino L et al (2000) Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein. Eur J Pharmacol 405:277\u2013283","journal-title":"Eur J Pharmacol"},{"key":"905_CR17","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1074\/jbc.M006285200","volume":"276","author":"DM Skovronsky","year":"2001","unstructured":"Skovronsky DM, Lee VM-Y, Pratic\u00f2 D (2001) Amyloid precursor protein and amyloid \u03b2 peptide in human platelets. J Biol Chem 276:17036\u201317043. https:\/\/doi.org\/10.1074\/jbc.M006285200","journal-title":"J Biol Chem"},{"key":"905_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0531-5565(02)00158-4","volume":"38","author":"M Racchi","year":"2003","unstructured":"Racchi M, Govoni S (2003) The pharmacology of amyloid precursor protein processing. Exp Gerontol 38:145\u2013157","journal-title":"Exp Gerontol"},{"key":"905_CR19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.emboj.7600061","volume":"23","author":"C Haass","year":"2004","unstructured":"Haass C (2004) Take five\u2013BACE and the gamma-secretase quartet conduct Alzheimer\u2019s amyloid beta-peptide generation. EMBO J 23:483\u2013488. https:\/\/doi.org\/10.1038\/sj.emboj.7600061","journal-title":"EMBO J"},{"key":"905_CR20","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00213-007-0748-5","volume":"192","author":"IA Zainaghi","year":"2007","unstructured":"Zainaghi IA, Forlenza OV, Gattaz WF (2007) Abnormal APP processing in platelets of patients with Alzheimer\u2019s disease: correlations with membrane fluidity and cognitive decline. Psychopharmacology 192:547\u2013553. https:\/\/doi.org\/10.1007\/s00213-007-0748-5","journal-title":"Psychopharmacology"},{"key":"905_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/156720508783954758","volume":"5","author":"SL Cole","year":"2008","unstructured":"Cole SL, Vassar R (2008) BACE1 structure and function in health and Alzheimer\u2019s disease. Curr Alzheimer Res 5:100\u2013120. https:\/\/doi.org\/10.2174\/156720508783954758","journal-title":"Curr Alzheimer Res"},{"key":"905_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1101\/gad.1039703","volume":"17","author":"DF Seals","year":"2003","unstructured":"Seals DF, Courtneidge SA (2003) The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev 17:7\u201330. https:\/\/doi.org\/10.1101\/gad.1039703","journal-title":"Genes Dev"},{"key":"905_CR23","doi-asserted-by":"publisher","first-page":"S37-43","DOI":"10.1016\/S0962-8924(01)02122-5","volume":"11","author":"C Chang","year":"2001","unstructured":"Chang C, Werb Z (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol 11:S37-43","journal-title":"Trends Cell Biol"},{"key":"905_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1471-4159.2011.07477.x","volume":"120","author":"V Vingtdeux","year":"2012","unstructured":"Vingtdeux V, Marambaud P (2012) Identification and biology of \u03b1-secretase. J Neurochem 120:34\u201345. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07477.x","journal-title":"J Neurochem"},{"key":"905_CR25","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1126\/science.1411576","volume":"258","author":"G Schellenberg","year":"1992","unstructured":"Schellenberg G, Bird T, Wijsman E et al (1992) Genetic linkage evidence for a familial Alzheimer\u2019s disease locus on chromosome 14. Science 258:668\u2013671. https:\/\/doi.org\/10.1126\/science.1411576","journal-title":"Science"},{"key":"905_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0896-6273(03)00205-8","volume":"38","author":"B Strooper De","year":"2003","unstructured":"De Strooper B (2003) Aph-1, Pen-2, and nicastrin with Presenilin generate an active \u03b3-secretase complex. Neuron 38:9\u201312","journal-title":"Neuron"},{"key":"905_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2005.09.002","volume":"240","author":"K Tang","year":"2006","unstructured":"Tang K, Hynan LS, Baskin F, Rosenberg RN (2006) Platelet amyloid precursor protein processing: a bio-marker for Alzheimer\u2019s disease. J Neurol Sci 240:53\u201358. https:\/\/doi.org\/10.1016\/j.jns.2005.09.002","journal-title":"J Neurol Sci"},{"key":"905_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00702-012-0807-x","volume":"119","author":"IA Zainaghi","year":"2012","unstructured":"Zainaghi IA, Talib LL, Diniz BS et al (2012) Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer\u2019s disease. J Neural Transm 119:815\u2013819. https:\/\/doi.org\/10.1007\/s00702-012-0807-x","journal-title":"J Neural Transm"},{"key":"905_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/15622970701535502","volume":"9","author":"BSO Diniz","year":"2008","unstructured":"Diniz BSO, Pinto JA, Forlenza OV (2008) Do CSF total tau, phosphorylated tau, and \u03b2-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer\u2019s disease? A systematic review and meta-analysis of the literature. World J Biol Psychiatry 9:172\u2013182. https:\/\/doi.org\/10.1080\/15622970701535502","journal-title":"World J Biol Psychiatry"},{"key":"905_CR30","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s12017-015-8361-y","volume":"17","author":"OV Forlenza","year":"2015","unstructured":"Forlenza OV, Diniz BS, Teixeira AL et al (2015) Lower cerebrospinal fluid concentration of brain-derived neurotrophic factor predicts progression from mild cognitive impairment to Alzheimer\u2019s disease. NeuroMol Med 17:326\u2013332. https:\/\/doi.org\/10.1007\/s12017-015-8361-y","journal-title":"NeuroMol Med"},{"key":"905_CR31","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.dadm.2015.09.003","volume":"1","author":"OV Forlenza","year":"2015","unstructured":"Forlenza OV, Radanovic M, Talib LL et al (2015) Cerebrospinal fluid biomarkers in Alzheimer\u2019s disease: diagnostic accuracy and prediction of dementia. Alzheimer\u2019s dement diagnosis. Assess Dis Monit 1:455\u2013463. https:\/\/doi.org\/10.1016\/j.dadm.2015.09.003","journal-title":"Assess Dis Monit"},{"key":"905_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0304-3940(92)90921-S","volume":"138","author":"JE Gardella","year":"1992","unstructured":"Gardella JE, Gorgone GA, Newman P et al (1992) Characterization of Alzheimer amyloid precursor protein transcripts in platelets and megakarocytes. Neurosci Lett 138:229\u2013232. https:\/\/doi.org\/10.1016\/0304-3940(92)90921-S","journal-title":"Neurosci Lett"},{"key":"905_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/2051-5960-2-65","volume":"2","author":"M Veitinger","year":"2014","unstructured":"Veitinger M, Varga B, Guterres SB, Zellner M (2014) Platelets, a reliable source for peripheral Alzheimer\u2019s disease biomarkers? Acta Neuropathol Commun 2:65. https:\/\/doi.org\/10.1186\/2051-5960-2-65","journal-title":"Acta Neuropathol Commun"},{"key":"905_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/archneur.1997.00550140019007","volume":"54","author":"RN Rosenberg","year":"1997","unstructured":"Rosenberg RN, Baskin F, Fosmire JA et al (1997) Altered amyloid protein processing in platelets of patients with Alzheimer disease. Arch Neurol 54:139\u2013144","journal-title":"Arch Neurol"},{"key":"905_CR35","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1001\/archneur.55.9.1179","volume":"55","author":"AI Bush","year":"1998","unstructured":"Bush AI, Tanzi RE (1998) Alzheimer-disease-related abnormalities of amyloid \u03b2 precursor protein isoforms in the platelet\u2014the brains delegate in the periphery. Arch Neurol 55:1179\u20131180. https:\/\/doi.org\/10.1001\/archneur.55.9.1179","journal-title":"Arch Neurol"},{"key":"905_CR36","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archneur.55.9.1195","volume":"55","author":"M Luca Di","year":"1998","unstructured":"Di Luca M (1998) Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol 55:1195\u20131200. https:\/\/doi.org\/10.1001\/archneur.55.9.1195","journal-title":"Arch Neurol"},{"key":"905_CR37","first-page":"461","volume":"78","author":"Q Li","year":"1998","unstructured":"Li Q, Whyte S, Tanner J et al (1998) Secretion of Alzheimer\u2019s disease Abeta amyloid peptide by activated human platelets. Lab Investig 78:461\u2013469","journal-title":"Lab Investig"},{"key":"905_CR38","doi-asserted-by":"publisher","first-page":"14140","DOI":"10.1074\/jbc.270.23.14140","volume":"270","author":"QX Li","year":"1995","unstructured":"Li QX, Evin G, Small DH et al (1995) Proteolytic processing of Alzheimer\u2019s disease ?\u03b2A4 amyloid precursor protein in human platelets. J Biol Chem 270:14140\u201314147. https:\/\/doi.org\/10.1074\/jbc.270.23.14140","journal-title":"J Biol Chem"},{"key":"905_CR39","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/jnr.10745","volume":"74","author":"G Evin","year":"2003","unstructured":"Evin G, Zhu A, Holsinger RMD et al (2003) Proteolytic processing of the Alzheimer\u2019s disease amyloid precursor protein in brain and platelets. J Neurosci Res 74:386\u2013392. https:\/\/doi.org\/10.1002\/jnr.10745","journal-title":"J Neurosci Res"},{"key":"905_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0896-6273(90)90100-T","volume":"4","author":"TE Golde","year":"1990","unstructured":"Golde TE, Estus S, Usiak M et al (1990) Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in alzheimer\u2019s disease using PCR. Neuron 4:253\u2013267. https:\/\/doi.org\/10.1016\/0896-6273(90)90100-T","journal-title":"Neuron"},{"key":"905_CR41","doi-asserted-by":"crossref","first-page":"23950","DOI":"10.1016\/S0021-9258(18)35929-5","volume":"267","author":"U M\u00f6nning","year":"1992","unstructured":"M\u00f6nning U, K\u00f6nig G, Banati RB et al (1992) Alzheimer beta A4-amyloid protein precursor in immunocompetent cells. J Biol Chem 267:23950\u201323956","journal-title":"J Biol Chem"},{"key":"905_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1182\/blood.V84.1.133.133","volume":"84","author":"QX Li","year":"1994","unstructured":"Li QX, Berndt MC, Bush AI et al (1994) Membrane-associated forms of the beta A4 amyloid protein precursor of Alzheimer\u2019s disease in human platelet and brain: surface expression on the activated human platelet. Blood 84:133\u2013142","journal-title":"Blood"},{"key":"905_CR43","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.neurobiolaging.2012.12.004","volume":"34","author":"E Delvaux","year":"2013","unstructured":"Delvaux E, Bentley K, Stubbs V et al (2013) Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes. Neurobiol Aging 34:1680\u20131686. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.12.004","journal-title":"Neurobiol Aging"},{"key":"905_CR44","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3233\/JAD-150737","volume":"50","author":"F Schuck","year":"2016","unstructured":"Schuck F, Wolf D, Fellgiebel A, Endres K (2016) Increase of \u03b1-secretase ADAM10 in platelets along cognitively healthy aging. J Alzheimer\u2019s Dis 50:817\u2013826. https:\/\/doi.org\/10.3233\/JAD-150737","journal-title":"J Alzheimer\u2019s Dis"},{"key":"905_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0014-5793(96)00845-9","volume":"393","author":"R Vidal","year":"1996","unstructured":"Vidal R, Ghiso J, Wisniewski T, Frangione B (1996) Alzheimer\u2019s presenilin 1 gene expression in platelets and megakaryocytes. FEBS Lett 393:19\u201323. https:\/\/doi.org\/10.1016\/0014-5793(96)00845-9","journal-title":"FEBS Lett"},{"key":"905_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/BF03402076","volume":"8","author":"F Colciaghi","year":"2002","unstructured":"Colciaghi F, Borroni B, Pastorino L et al (2002) [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 8:67\u201374","journal-title":"Mol Med"},{"key":"905_CR47","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/09537104.2012.688899","volume":"24","author":"B Decourt","year":"2013","unstructured":"Decourt B, Walker A, Gonzales A et al (2013) Can platelet BACE1 levels be used as a biomarker for Alzheimer\u2019s disease? Proof-of-concept study. Platelets 24:235\u2013238. https:\/\/doi.org\/10.3109\/09537104.2012.688899","journal-title":"Platelets"},{"key":"905_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000345983","volume":"35","author":"PR Manzine","year":"2013","unstructured":"Manzine PR, de Fran\u00e7a Bram JM, Barham EJ et al (2013) ADAM10 as a biomarker for Alzheimer\u2019s disease: a Study with Brazilian Elderly. Dement Geriatr Cogn Disord 35:58\u201366. https:\/\/doi.org\/10.1159\/000345983","journal-title":"Dement Geriatr Cogn Disord"},{"key":"905_CR49","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/15672026113109990022","volume":"10","author":"J Marksteiner","year":"2013","unstructured":"Marksteiner J, Humpel C (2013) Platelet-derived secreted amyloid-precursor protein-\u03b2 as a marker for diagnosing Alzheimer\u2019s disease. Curr Neurovasc Res 10:297\u2013303","journal-title":"Curr Neurovasc Res"},{"key":"905_CR50","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3233\/JAD-160813","volume":"55","author":"TA Sarno","year":"2017","unstructured":"Sarno TA, Talib LL, Joaquim HPG et al (2017) Protein expression of BACE1 is downregulated by Donepezil in Alzheimer\u2019s disease platelets. J Alzheimers Dis 55:1445\u20131451. https:\/\/doi.org\/10.3233\/JAD-160813","journal-title":"J Alzheimers Dis"},{"key":"905_CR51","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1006\/geno.1996.4523","volume":"40","author":"EI Rogaev","year":"1997","unstructured":"Rogaev EI, Sherrington R, Wu C et al (1997) Analysis of the 5? Sequence, genomic structure, and alternative splicing of thepresenilin-1gene (psen1) associated with early onset Alzheimer disease. Genomics 40:415\u2013424. https:\/\/doi.org\/10.1006\/geno.1996.4523","journal-title":"Genomics"},{"issue":"Suppl 2","key":"905_CR52","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3233\/JAD-2011-110017","volume":"24","author":"B Decourt","year":"2011","unstructured":"Decourt B, Sabbagh MN (2011) BACE1 as a potential biomarker for Alzheimer\u2019s disease. J Alzheimers Dis 24(Suppl 2):53\u201359. https:\/\/doi.org\/10.3233\/JAD-2011-110017","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"905_CR53","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.neurobiolaging.2012.12.004","volume":"34","author":"Elaine Delvaux","year":"2013","unstructured":"Delvaux E, Bentley K, Stubbs V et al Differential processing of amyloid precursor protein in brain and in peripheral blood leukocytes. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.12.004","journal-title":"Neurobiology of Aging"},{"key":"905_CR54","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC","edition":"4"},{"key":"905_CR55","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34:939\u2013939. https:\/\/doi.org\/10.1212\/WNL.34.7.939","journal-title":"Neurology"},{"key":"905_CR56","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1192\/bjp.149.6.698","volume":"149","author":"M Roth","year":"1986","unstructured":"Roth M, Tym E, Mountjoy CQ (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698\u2013709. https:\/\/doi.org\/10.1192\/bjp.149.6.698","journal-title":"Br J Psychiatry"},{"key":"905_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"key":"905_CR58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"O Lowry","year":"1951","unstructured":"Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265\u2013275","journal-title":"J Biol Chem"},{"key":"905_CR59","unstructured":"SPSS Incorporation (2006) Statistical Package for Social Science (SPSS). Release version 14 Chicago (IL). In: SPSS Inc. http:\/\/www.scielo.br\/scielo.php?script=sci_nlinks&ref=000114&pid=S0365-0596201000010000300018&lng=pt . Accessed 12 Mar 2018"},{"key":"905_CR60","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s11064-013-1039-7","volume":"38","author":"P Bermejo-Besc\u00f3s","year":"2013","unstructured":"Bermejo-Besc\u00f3s P, Mart\u00edn-Arag\u00f3n S, Jim\u00e9nez-Aliaga K et al (2013) Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI). Neurochem Res 38:1415\u20131423. https:\/\/doi.org\/10.1007\/s11064-013-1039-7","journal-title":"Neurochem Res"},{"key":"905_CR61","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R (1999) Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286:735\u2013741. https:\/\/doi.org\/10.1126\/science.286.5440.735","journal-title":"Science"},{"key":"905_CR62","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1046\/j.1471-4159.2000.0752133.x","volume":"75","author":"M Marcinkiewicz","year":"2000","unstructured":"Marcinkiewicz M, Seidah NG (2000) Coordinated expression of \u03b2-amyloid precursor protein and the putative \u03b2-secretase BACE and \u03b1-secretase ADAM10 in mouse and human brain. J Neurochem 75:2133\u20132143. https:\/\/doi.org\/10.1046\/j.1471-4159.2000.0752133.x","journal-title":"J Neurochem"},{"key":"905_CR63","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","volume":"13","author":"R Yan","year":"2014","unstructured":"Yan R, Vassar R (2014) Targeting the \u03b2 secretase BACE1 for Alzheimer\u2019s disease therapy. Lancet Neurol 13:319\u2013329. https:\/\/doi.org\/10.1016\/S1474-4422(13)70276-X","journal-title":"Lancet Neurol"},{"key":"905_CR64","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1590\/0001-376520130013","volume":"85","author":"M Herrera-Rivero","year":"2013","unstructured":"Herrera-Rivero M, Soto-Cid A, Hern\u00e1ndez ME, Aranda-Abreu GE (2013) Tau, APP, NCT and BACE1 in lymphocytes through cognitively normal ageing and neuropathology. An Acad Bras Cienc 85:1489\u20131496. https:\/\/doi.org\/10.1590\/0001-376520130013","journal-title":"An Acad Bras Cienc"},{"key":"905_CR65","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jtbi.2015.03.039","volume":"376","author":"M Herrera-Rivero","year":"2015","unstructured":"Herrera-Rivero M, Elena Hern\u00e1ndez-Aguilar M, Emiliano Aranda-Abreu G (2015) A strategy focused on MAPT, APP, NCSTN and BACE1 to build blood classifiers for Alzheimer\u2019s disease. J Theor Biol 376:32\u201338. https:\/\/doi.org\/10.1016\/j.jtbi.2015.03.039","journal-title":"J Theor Biol"},{"key":"905_CR66","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/ana.10208","volume":"51","author":"RMD Holsinger","year":"2002","unstructured":"Holsinger RMD, McLean CA, Beyreuther K et al (2002) Increased expression of the amyloid precursor \u03b2-secretase in Alzheimer\u2019s disease. Ann Neurol 51:783\u2013786. https:\/\/doi.org\/10.1002\/ana.10208","journal-title":"Ann Neurol"},{"key":"905_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/nm0103-3","volume":"9","author":"L-B Yang","year":"2003","unstructured":"Yang L-B, Lindholm K, Yan R et al (2003) Elevated \u03b2-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9:3\u20134. https:\/\/doi.org\/10.1038\/nm0103-3","journal-title":"Nat Med"},{"key":"905_CR68","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","volume":"59","author":"H Fukumoto","year":"2002","unstructured":"Fukumoto H (2002) \u03b2-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59:1381. https:\/\/doi.org\/10.1001\/archneur.59.9.1381","journal-title":"Arch Neurol"},{"key":"905_CR69","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1471-4159.2009.06528.x","volume":"112","author":"RR Ahmed","year":"2010","unstructured":"Ahmed RR, Holler CJ, Webb RL et al (2010) BACE1 and BACE2 enzymatic activities in Alzheimer\u2019s disease. J Neurochem 112:1045\u20131053. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06528.x","journal-title":"J Neurochem"},{"key":"905_CR70","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1212\/01.wnl.0000229925.52203.4c","volume":"67","author":"RMD Holsinger","year":"2006","unstructured":"Holsinger RMD, Lee JS, Boyd A et al (2006) CSF BACE1 activity is increased in CJD and Alzheimer disease versus other dementias. Neurology 67:710\u2013712. https:\/\/doi.org\/10.1212\/01.wnl.0000229925.52203.4c","journal-title":"Neurology"},{"key":"905_CR71","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1373\/clinchem.2006.066720","volume":"52","author":"JH Verheijen","year":"2006","unstructured":"Verheijen JH, Huisman LGM, Van Lent N et al (2006) Detection of a soluble form of BACE-1 in human cerebrospinal fluid by a sensitive activity assay. Clin Chem 52:1168\u20131174. https:\/\/doi.org\/10.1373\/clinchem.2006.066720","journal-title":"Clin Chem"},{"key":"905_CR72","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/archpsyc.64.6.718","volume":"64","author":"Z Zhong","year":"2007","unstructured":"Zhong Z, Ewers M, Teipel S et al (2007) Levels of \u03b2-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Arch Gen Psychiatry 64:718. https:\/\/doi.org\/10.1001\/archpsyc.64.6.718","journal-title":"Arch Gen Psychiatry"},{"key":"905_CR73","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1001\/archneur.65.8.1102","volume":"65","author":"H Zetterberg","year":"2008","unstructured":"Zetterberg H, Andreasson U, Hansson O et al (2008) Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease. Arch Neurol 65:1102\u20131107. https:\/\/doi.org\/10.1001\/archneur.65.8.1102","journal-title":"Arch Neurol"},{"key":"905_CR74","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3233\/JAD-2010-1367","volume":"20","author":"SD Mulder","year":"2010","unstructured":"Mulder SD, van der Flier WM, Verheijen JH et al (2010) BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology. J Alzheimer\u2019s Dis 20:253\u2013260. https:\/\/doi.org\/10.3233\/JAD-2010-1367","journal-title":"J Alzheimer\u2019s Dis"},{"key":"905_CR75","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/alzrt82","volume":"3","author":"R Vassar","year":"2011","unstructured":"Vassar R, Kandalepas PC (2011) The \u03b2-secretase enzyme BACE1 as a therapeutic target for Alzheimer\u2019s disease. Alzheimers Res Ther 3:20. https:\/\/doi.org\/10.1186\/alzrt82","journal-title":"Alzheimers Res Ther"},{"key":"905_CR76","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fnmol.2017.00056","volume":"10","author":"K Endres","year":"2017","unstructured":"Endres K, Deller T (2017) Regulation of alpha-secretase ADAM10 in vitro and in vivo: genetic, epigenetic, and protein-based mechanisms. Front Mol Neurosci 10:56. https:\/\/doi.org\/10.3389\/fnmol.2017.00056","journal-title":"Front Mol Neurosci"},{"key":"905_CR77","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00221-011-2932-4","volume":"217","author":"D K\u00f6gel","year":"2012","unstructured":"K\u00f6gel D, Deller T, Behl C (2012) Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging. Exp Brain Res 217:471\u2013479. https:\/\/doi.org\/10.1007\/s00221-011-2932-4","journal-title":"Exp Brain Res"},{"key":"905_CR78","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.mam.2008.08.001","volume":"29","author":"DR Edwards","year":"2009","unstructured":"Edwards DR, Handsley MM, Pennington CJ (2009) The ADAM metalloproteinases. Mol Aspects Med 29:258\u2013289","journal-title":"Mol Aspects Med"},{"key":"905_CR79","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.semcdb.2008.11.002","volume":"20","author":"K Reiss","year":"2009","unstructured":"Reiss K, Saftig P (2009) The A Disintegrin And Metalloprotease (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol 20:126\u2013137. https:\/\/doi.org\/10.1016\/j.semcdb.2008.11.002","journal-title":"Semin Cell Dev Biol"},{"key":"905_CR80","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/BF03401825","volume":"6","author":"PM Mathews","year":"2000","unstructured":"Mathews PM, Cataldo AM, Kao BH et al (2000) Brain expression of presenilins in sporadic and early-onset, familial Alzheimer\u2019s disease. Mol Med 6:878\u2013891","journal-title":"Mol Med"},{"key":"905_CR81","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3233\/JAD-2010-100729","volume":"22","author":"R Borghi","year":"2010","unstructured":"Borghi R, Piccini A, Barini E et al (2010) Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 22:771\u2013775. https:\/\/doi.org\/10.3233\/JAD-2010-100729","journal-title":"J Alzheimer\u2019s Dis"},{"key":"905_CR82","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/emmm.201200214","volume":"4","author":"N Kakuda","year":"2012","unstructured":"Kakuda N, Shoji M, Arai H et al (2012) Altered \u03b3-secretase activity in mild cognitive impairment and Alzheimer\u2019s disease. EMBO Mol Med 4:344\u2013352. https:\/\/doi.org\/10.1002\/emmm.201200214","journal-title":"EMBO Mol Med"},{"key":"905_CR83","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000051266","volume":"12","author":"P Davidsson","year":"2001","unstructured":"Davidsson P, Bogdanovic N, Lannfelt L, Blennow K (2001) Reduced expression of amyloid precursor protein, presenilin-1 and rab3a in cortical brain regions in Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 12:243\u2013250","journal-title":"Dement Geriatr Cogn Disord"},{"key":"905_CR84","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1212\/01.WNL.0000141848.45315.A6","volume":"63","author":"G Verdile","year":"2004","unstructured":"Verdile G, Gnjec A, Miklossy J et al (2004) Protein markers for Alzheimer disease in the frontal cortex and cerebellum. Neurology 63:1385\u20131392. https:\/\/doi.org\/10.1212\/01.WNL.0000141848.45315.A6","journal-title":"Neurology"},{"issue":"8","key":"905_CR85","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.1074\/jbc.M409106200","volume":"280","author":"Anja Capell","year":"2004","unstructured":"Capell A, Beher D, Prokop S et al (2004) \u03b3-secretase complex assembly within the early secretory pathway*. https:\/\/doi.org\/10.1074\/jbc.M409106200","journal-title":"Journal of Biological Chemistry"},{"key":"905_CR86","doi-asserted-by":"publisher","first-page":"7148","DOI":"10.1073\/pnas.1705240114","volume":"114","author":"V Bustos","year":"2017","unstructured":"Bustos V, Pulina MV, Bispo A et al (2017) Phosphorylated Presenilin 1 decreases \u03b2-amyloid by facilitating autophagosome\u2013lysosome fusion. Proc Natl Acad Sci USA 114:7148\u20137153. https:\/\/doi.org\/10.1073\/pnas.1705240114","journal-title":"Proc Natl Acad Sci USA"},{"key":"905_CR87","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-7091-8582-7_2","author":"A Pletscher","year":"1980","unstructured":"Pletscher A, Laubscher A (1980) Blood platelets as models for neurons: uses and limitations. J Neural Transm. https:\/\/doi.org\/10.1007\/978-3-7091-8582-7_2","journal-title":"J Neural Transm"},{"key":"905_CR88","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1007\/s00431-007-0543-7","volume":"166","author":"K Freson","year":"2007","unstructured":"Freson K, Labarque V, Thys C et al (2007) What\u2019s new in using platelet research? To unravel thrombopathies and other human disorders. Eur J Pediatr 166:1203\u20131210. https:\/\/doi.org\/10.1007\/s00431-007-0543-7","journal-title":"Eur J Pediatr"},{"key":"905_CR89","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-4933-9-20","volume":"9","author":"S Catricala","year":"2012","unstructured":"Catricala S, Torti M, Ricevuti G (2012) Alzheimer disease and platelets: how\u2019s that relevant. Immun Ageing 9:20. https:\/\/doi.org\/10.1186\/1742-4933-9-20","journal-title":"Immun Ageing"},{"key":"905_CR90","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5498\/wjp.v2.i6.95","volume":"2","author":"LL Talib","year":"2012","unstructured":"Talib LL, Joaquim HP, Forlenza OV (2012) Platelet biomarkers in Alzheimer\u2019s disease. World J psychiatry 2:95\u2013101. https:\/\/doi.org\/10.5498\/wjp.v2.i6.95","journal-title":"World J psychiatry"},{"key":"905_CR91","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/00207454.2012.751534","volume":"123","author":"M Behari","year":"2013","unstructured":"Behari M, Shrivastava M (2013) Role of platelets in neurodegenerative diseases: a universal pathophysiology. Int J Neurosci 123:287\u2013299. https:\/\/doi.org\/10.3109\/00207454.2012.751534","journal-title":"Int J Neurosci"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-018-0905-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-018-0905-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-018-0905-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T12:50:21Z","timestamp":1661345421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-018-0905-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":91,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["905"],"URL":"https:\/\/doi.org\/10.1007\/s00406-018-0905-3","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]},"assertion":[{"value":"7 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}